Skip to main content

Table 2 Change in Postpartum Calculated CrCl from Delivery by Postpartum TDF Exposure*

From: Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

Postpartum TDF exposure

Change in Calculated CrCl (mL/min)

TDF-ART

(N = 445)

ZDV-ART

(N = 447)

ZDV alone

(N = 446)

Week 6—delivery

    

 TDF

N

188

207

190

 

Mean (95% CI)

− 23.7 (− 29.6, − 17.8)

− 38.6 (− 43.1, − 34.1)

− 38.6 (− 42.6, − 34.5)

 

Mean difference (95% CI) from TDF-ART

 

14.9 (7.0, 22.8)

14.8 (6.7, 23.0)

 No TDF

N

199

189

212

 

Mean (95% CI)

− 12.5 (− 20.1, − 5.0)

− 27.0 (− 31.0, − 23.0)

− 31.7 (− 36.4, − 27.0)

 

Mean difference (95% CI) from TDF-ART

 

14.5 (6.5, 22.5)

19.2 (11.3, 27.0)

Week 26—delivery

    

 TDF

N

192

206

195

 

Mean (95% CI)

− 17.9 (− 24.8, − 11.1)

− 28.4 (− 34.5, − 22.4)

− 29.3 (− 33.3, − 25.3)

 

Mean difference (95% CI) from TDF-ART

 

10.5 (2.1, 18.9)

11.4 (4.0, 18.7)

 No TDF

N

193

184

188

 

Mean (95% CI)

− 8.6 (− 12.8, − 4.3)

− 19.0 (− 25.7, − 12.3)

− 26.2 (− 31.6, − 20.9)

 

Mean difference (95% CI) from TDF-ART

 

10.4 (1.8, 19.1)

17.7 (10.3, 25.1)

Week 24—delivery

    

 TDF

N

97

72

75

 

Mean (95% CI)

− 8.4 (− 14.8, − 2.0)

− 30.7 (− 37.2, − 24.1)

− 32.2 (− 42.3, − 22.2)

 

Mean difference (95% CI) from TDF-ART

 

22.3 (12.1, 32.5)

23.9 (12.0, 35.7)

 No TDF

N

74

86

82

 

Mean (95% CI)

− 5.2 (− 13.4, 3.0)

− 16.6 (− 24.6, − 8.6)

− 19.5 (− 29.6, − 9.5)

 

Mean difference (95% CI) from TDF-ART

 

11.4 (1.0, 21.8)

14.3 (2.0, 26.6)

Week 6—delivery

    

 TDF

N

188

207

190

 

Mean (95% CI)

− 23.7 (− 29.6, − 17.8)

− 38.6 (− 43.1, − 34.1)

− 38.6 (− 42.6, − 34.5)

 

Mean difference (95% CI) from TDF-ART

 

14.9 (7.0, 22.8)

14.8 (6.7, 23.0)

 No TDF

N

199

189

212

 

Mean (95% CI)

− 12.5 (− 20.1, − 5.0)

− 27.0 (− 31.0, − 23.0)

− 31.7 (− 36.4, − 27.0)

 

Mean difference (95% CI) from TDF-ART

 

14.5 (6.5, 22.5)

19.2 (11.3, 27.0)

Week 26—delivery

    

 TDF

N

192

206

195

 

Mean (95% CI)

− 17.9 (− 24.8, − 11.1)

− 28.4 (− 34.5, − 22.4)

− 29.3 (− 33.3, − 25.3)

 

Mean difference (95% CI) from TDF-ART

 

10.5 (2.1, 18.9)

11.4 (4.0, 18.7)

 No TDF

N

193

184

188

 

Mean (95% CI)

− 8.6 (− 12.8, − 4.3)

− 19.0 (− 25.7, − 12.3)

− 26.2 (− 31.6, − 20.9)

 

Mean difference (95% CI) from TDF-ART

 

10.4 (1.8, 19.1)

17.7 (10.3, 25.1)

Week 74—delivery

    

 TDF

N

97

72

75

 

Mean (95% CI)

− 8.4 (− 14.8, − 2.0)

− 30.7 (− 37.2, − 24.1)

− 32.2 (− 42.3, − 22.2)

 

Mean difference (95% CI) from TDF-ART

 

22.3 (12.1, 32.5)

23.9 (12.0, 35.7)

 No TDF

N

74

86

82

 

Mean (95% CI)

− 5.2 (− 13.4, 3.0)

− 16.6 (− 24.6, − 8.6)

− 19.5 (− 29.6, − 9.5)

 

Mean difference (95% CI) from TDF-ART

 

11.4 (1.0, 21.8)

14.3 (2.0, 26.6)

  1. *Among women eligible for TDF randomization
  2. CrCl creatinine clearance, TDF tenofovir disoproxil fumarate, ZDV zidovudine, CI confidence interval